Journal Mobile Options
Table of Contents
Vol. 228, No. 3, 2014
Issue release date: June 2014
Dermatology 2014;228:193-197

Sight-Threatening Ocular Manifestations of Acute Febrile Neutrophilic Dermatosis (Sweet's Syndrome)

Baartman B. · Kosari P. · Warren C.C. · Ali S. · Jorizzo J.L. · Sato M. · Kurup S.K.
aDepartment of Ophthalmology, Wake Forest University Eye Center, and Departments of bDermatology and cPathology, Wake Forest University Baptist Medical Center, Winston-Salem, N.C., USA; dDepartment of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Sweet's syndrome is a primarily dermatologic disorder with many features of systemic inflammation. It is generally characterized by a neutrophilic dermatosis in the setting of fever and an elevated white blood cell count. Inflammation has been described to occur in many organ systems including the lung, bone, liver, spleen, brain and eye. Ocular inflammation is a well-known comorbidity that may occur in the setting of Sweet's syndrome, including conjunctivitis, episcleritis, scleritis, iritis and choroiditis, among other forms. In the current article, we have compiled a series of cases that describe three separate patients who demonstrated a rare form of ocular involvement in Sweet's syndrome, retinal vasculitis. The evidence from these three cases and other reports in recent ophthalmologic literature suggest overlapping of ocular manifestations of Sweet's syndrome and the closely related Behçet's disease. It is important to be aware of the sometimes challenging differential between these two disorders and their sight-threatening complications. © 2014 S. Karger AG, Basel

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Gottlieb CC, Mishra A, Belliveau D, Green P, Heathcote JG: Ocular involvement in acute febrile neutrophilic dermatosis (Sweet syndrome): new cases and review of the literature. Surv Ophthalmol 2008;53:219-226.
  2. Sato M, Kawamura T, Hase S, Katsumata S, Oshika T: A case of bilateral retinal vasculitis associated with Sweet syndrome. Retina 2005;25:800-802.
  3. Matsumiya W, Kusuhara S, Yamada Y, Azumi A, Negi A: Sweet's syndrome with panuveitis resembling Behcet's disease. Jpn J Ophthalmol 2012;56:268-272.
  4. Sweet RD: An acute febrile neutrophilic dermatosis. Br J Dermatol 1964;76:349-356.
  5. Wojcik AS, Nishimori FS, Santamaría JR: Sweet's syndrome: a study of 23 cases. An Bras Dermatol 2011;86:265-271.
  6. Anzalone CL, Cohen PR: Acute febrile neutrophilic dermatosis (Sweet's syndrome). Curr Opin Hematol 2013;20:26-35.
  7. Rochael MC, Pantaleao L, Vilar EA, Zacaron LH, Spada EQ, Xavier MH, Rodrigues KS: Sweet's syndrome: study of 73 cases, emphasizing histopathological findings. An Bras Dermatol 2011;86:702-707.
  8. Cohen PR, Almeida L, Kurzrock R: Acute febrile neutrophilic dermatosis. Am Fam Physician 1989;39:199-204.

    External Resources

  9. Bonamigo RR, Razera F, Olm GS: Neutrophilic dermatoses: part I. An Bras Dermatol 2011;86:11-25; quiz 26-27.
  10. Hassikou H, Tabache F, Baaj M, Safi S, Hadri L: Sweet's syndrome in Behcet's disease. Joint Bone Spine 2007;74:495-496.
  11. Medenblik-Frysch S, von den Driesch P, Jonas JB, Meythaler FH: Ocular complications in Sweet's syndrome. Am J Ophthalmol 1992;114:230-231.

    External Resources

  12. Walton RC, Ashmore ED: Retinal vasculitis. Curr Opin Ophthalmol 2003;14:413-419.
  13. Howe LJ, Stanford MR, Edelsten C, Graham EM: The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis. Eye (Lond) 1994;8:443-447.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50